Brief report · 30 Mar 2026
Case reportPublished 2017
Successful Treatment of Familial Mediterranean Fever with Infliximab in a Colchicine Resistant Patient
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by recurrent episodes of fever and inflammation. Approximately 10% of patients are reported to be resistant or non-responsive to colchicine. We describe a case of a 30-year-old female patient with familial Mediterranean fever resistant to treatment with colchicine and lack of clinical response to Anakinra, successfully treated with Infliximab. Our case suggests that Infliximab, an anti-TNF antibody, may represent a safe and effective therapy for the treatment of colchicine-resistant FMF.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Case Reports.
Opinion · 30 Mar 2026
Atypical Multiple Sclerosis in Young Adults: Challenges and Management
Brief report · 30 Mar 2026
Stress-Induced Heart Failure: The Mind-Heart Connection
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Case Reports
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Makiko Tajika”
- BylineArticles whose byline prints “Mai Arai”
- BylineArticles whose byline prints “Keiko Kobayashi”
- BylineArticles whose byline prints “Koichiro Fujimaki”
- BylineArticles whose byline prints “Kazunaga Agematsu”
- BylineArticles whose byline prints “Yoh Umeda”
